Methodology and logic of scientific research. Good clinical practice rules

Medical science is fundamentally characterized by an ethically determined methodology, a necessity arising from its unique object of study – the human being. This ethical foundation, reflecting the philosophical synthesis of empiricism and theory, is institutionally realized in international Good Clinical Practice (GCP) guidelines. These standards, a response to historical ethical failures and tragedies like the thalidomide disaster, prioritize participant rights, safety, and well-being over scientific objectives, while ensuring data reliability for regulatory approval. The cornerstone of GCP is informed consent, a formal process confirming voluntary and understanding participation.

Evidence-based medicine (EBM) is built upon a hierarchy of study designs, with the randomized controlled trial (RCT) remaining the «gold standard» for establishing causal inference due to its high internal validity. This validity is achieved via key methodological safeguards: randomization (mitigating selection bias), blinding (preventing expectation bias), and statistically powered sampling. A central challenge lies in balancing this internal validity with external generalizability–often necessitating pragmatic trial designs to ensure real-world relevance.

The 21st-century methodological landscape is now significantly expanded by real-world data and evidence (RWD/RWE), derived from sources like electronic health records and patient registries. While not supplanting controlled trials, RWD/RWE plays an increasingly critical role in post-marketing surveillance, orphan drug development, and expanding therapeutic indications. This creates a dynamic ecosystem of complementary research approaches, from RCTs to observational studies. Successfully navigating this ecosystem requires researchers to exercise sophisticated scientific and practical judgment to integrate evidence across methodologies.

In conclusion, modern clinical research methodology represents a deliberate synthesis of scientific philosophy, rigorous procedural standards (GCP and statistics), and uncompromising ethics. This integrated framework is designed to generate robust, actionable knowledge for improving human health.

1. Leonardo da Vinchi. Izbrannyye proizvedeniya [Selected works] / Leonardo da Vinchi. – M.; L.: Academia, 1935. – 364 p. [in Russian].

2. Mironov, V. B. Pir mudretsov [Feast of the Sages] / V. B. Mironov. – M.: [s. n.], 1994. – 301 p. [in Russian].

3. Filosofiya nauki i meditsiny [Philosophy of science and medicine] / Yu. M. Khrustalev, G. I. Tsaregorodtsev. – M.: GEOTAR-Media, 2007. – 512 p. [in Russian].

4. Vokhidova, Sh. Sh. Vliyaniye filosofii Frensis Bekona na razvitiye meditsinskoy nauki [The influence of Francis Bacon’s philosophy on the development of medical science] / Sh. Sh. Vokhidova, A. K. Cheremisina // Byulleten’ meditsinskikh internet-konferentsiy – 2017. – Vol. 7, № 6. – P. 954–956 [in Russian].

5. Fokin, S. L. Bolezn’ i zdorov’ye v filosofii Rene Dekarta [Illness and health in the philosophy of René Descartes] / S. L. Fokin // Vestnik Sankt-Peterburgskogo universiteta. Filosofiya i konfliktologiya. – 2018. – Vol. 34, № 3. – P. 381–390 [in Russian].

6. Lebedev, S. A. Struktura nauchnogo znaniya i yego urovni [The structure of scientific knowledge and its levels] / S. A. Lebedev // Zhurnal filosofskikh issledovaniy – 2016. – № 1. – P. 1 [in Russian].

7. Rebrova, O. Yu. Statisticheskiy analiz meditsinskikh dannykh [Statistical analysis of medical data] / O. Yu. Rebrova. – M.: Media Sfera, 2003. – 312 p. [in Russian].

8. Revtovich, M. Y u., Goloborod’ko N. V., Trushel’ N. A. Sostavlenie formy informirovannogo soglasiya pri provedenii issledovanij na lyudyakh // Meditsinskij zhurnal. – 2025. – № 4. – Р. 138–147 [in Russian].

9. Pravila nadlezhashchey klinicheskoy praktiki Yevraziyskogo ekonomicheskogo soyuza [Good Clinical Practice Rules of the Eurasian Economic Union]: resheniye Soveta Yevraziyskoy ekonomicheskoy komissii ot 1 avg. 2025 g. № 63 – [S. l.: s. n.], 2025 [in Russian].

10. Flecher, R. Klinicheskaya epidemiologiya. Osnovy dokazatel’noy meditsiny [Clinical epidemiology. Fundamentals of evidence-based medicine] / R. Flecher, S. Flecher, E. Vagner. – 3rd ed. – M.: Media Sfera, 2004. – 352 p. [in Russian].

11. Tikhova, G. P. Planiroyem klinicheskoye issledovaniye. Vopros № 1: kak opredelit’ neobkhodimyy ob”yem vyborki? [Planning a clinical study. Question № 1: how to determine the required sample size?] / G. P. Tikhova // Regional’naya anesteziya i lecheniye ostroy boli. – 2014. – Vol. 8, № 3. – P. 57–63 [in Russian].

12. Bavrina, A. P. Osnovnyye ponyatiya statistiki [Basic concepts of statistics] / A. P. Bavrina // Meditsinskiy al’manakh. – 2020. – № 3(64). – P. 101–111 [in Russian].

13. Fayatt, G. Putevoditel’ chitatelya meditsinskoy literatury. Printsipy klinicheskoy praktiki, osnovannoy na dokazannom [Guide to the reader of medical literature. Principles of Evidence-Based Clinical Practice] / G. Fayatt. – M.: Media Sfera, 2003. – 382 p. [in Russian].

14. Kozhanova, I. N. Otsenka meditsinskikh tekhnologiy. Terminologiya [Health technology assessment. Terminology] / I. N. Kozhanova // Voprosy organizatsii i informatizatsii zdravookhraneniya. – 2021. – № 2(107). – P. 12–26 [in Russian].

15. Gopalakrishnan, S. Systematic Reviews and Metaanalysis: Understanding the Best Evidence in Primary Healthcare / S. Gopalakrishnan, P. Ganeshkumar // Journal of Family Medicine and Primary Care. – 2013. – Vol. 2, № 1. – P. 9–14.

16. Kolbin, A. S. Primeneniye dannykh real’noy klinicheskoy praktiki s pozitsii klinicheskoy farmakologii pri razrabotke lekarstvennykh sredstv [The use of real-world clinical practice data from the perspective of clinical pharmacology in drug development] / A. S. Kolbin, A. R. Niyazov // Klinicheskaya farmakologiya i terapiya. – 2023. – Vol. 32, № 4. – P. ... [in Russian].

17. Mursu, J. Dietary supplements and mortality rate in older women: the Iowa Women’s Health Study / J. Mursu, K. Robien, L. J. Harnack [et al.] // Archives of Internal Medicine. – 2011. – Vol. 171, № 18. – P. 1625–1633.

18. Kim, H. J. Association of multivitamin and mineral supplementation and risk of cardiovascular disease: a systematic review and meta-analysis / H. J. Kim, H. W. Lee, S. Y. Kim [et al.] // Circulation: Cardiovascular Quality and Outcomes. – 2018. – Vol. 11, № 7. – P. e004224.

19. Cuijpers, P. How effective are cognitive behavior therapies for major depression and anxiety disorders? A metaanalytic update of the evidence / P. Cuijpers, I. A. Cristea, E. Karyotaki, M. Reijnders, M. J. H. Huibers // World Psychiatry. – 2016. – Vol. 15, № 3. – P. 245–258.

20. Oreopoulos, A. Body mass index and mortality in heart failure: a meta-analysis / A. Oreopoulos, R. Padwal, K. Kalantar- Zadeh [et al.] // American Heart Journal. – 2008. – Vol. 156, № 1. – P. 13–22.

21. Padwal, R. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a metaanalysis of individual patient data / R. Padwal, F. A. McAlister, J. J. McMurray [et al.]; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) // International Journal of Obesity. – 2014. – Vol. 38, № 8. – P. 1110–1114.